Zobrazeno 1 - 10
of 18
pro vyhledávání: '"V P, Scantlebury"'
Autor:
R, Shapiro, M L, Jordan, V P, Scantlebury, C A, Vivas, A, Jain, P, Chakrabarti, J, McCauley, J, Johnston, P, Randhawa, A, Rao, J J, Fung, R J, Corry
Publikováno v:
Clinical transplants.
Analysis of the SPK program at the University of Pittsburgh has led to a number of observations: 1. Under tacrolimus-based immunosuppression, without antibody induction, it has been possible to achieve (a) One- and 3-year actuarial patient survival r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::78afb5b713cde1e945f30e51cc033304
https://pubmed.ncbi.nlm.nih.gov/11038640
https://pubmed.ncbi.nlm.nih.gov/11038640
Autor:
P, Chakrabarti, H Y, Wong, V P, Scantlebury, M L, Jordan, C, Vivas, D, Ellis, S, Lombardozzi-Lane, T R, Hakala, J J, Fung, R L, Simmons, T E, Starzl, R, Shapiro
Publikováno v:
Transplantation. 70(5)
Corticosteroids have always been an integral part of immunosuppressive regimens in renal transplantation. The primary goal of this analysis was to assess the safety of steroid withdrawal in our pediatric renal transplant recipients receiving tacrolim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e596eac4156194824c297e7209a0e67
https://pubmed.ncbi.nlm.nih.gov/11003353
https://pubmed.ncbi.nlm.nih.gov/11003353
Autor:
R, Shapiro, M, Nalesnik, J, McCauley, S, Fedorek, M L, Jordan, V P, Scantlebury, A, Jain, C, Vivas, D, Ellis, S, Lombardozzi-Lane, P, Randhawa, J, Johnston, T R, Hakala, R L, Simmons, J J, Fung, T E, Starzl
Publikováno v:
Transplantation. 68(12)
Between March 27, 1989 and December 31, 1997, 1316 kidney transplantations alone were performed under tacrolimus-based immunosuppression at our center. Posttransplant lymphoproliferative disorders (PTLD) developed in 25 (1.9%) cases; the incidence in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9166251ba91afd0c0656ab73529d539
https://pubmed.ncbi.nlm.nih.gov/10628763
https://pubmed.ncbi.nlm.nih.gov/10628763
Autor:
R, Shapiro, V P, Scantlebury, M L, Jordan, C, Vivas, D, Ellis, S, Lombardozzi-Lane, N, Gilboa, H A, Gritsch, W, Irish, J, McCauley, J J, Fung, T R, Hakala, R L, Simmons, T E, Starzl
Publikováno v:
Transplantation. 67(2)
Tacrolimus has been used as a primary immunosuppressive agent in adult and pediatric renal transplant recipients, with reasonable outcomes. Methods. Between December 14, 1989 and December 31, 1996, 82 pediatric renal transplantations alone were perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::04a70b0a77bab5513553f8ce3a7d2191
https://pubmed.ncbi.nlm.nih.gov/10075598
https://pubmed.ncbi.nlm.nih.gov/10075598
Autor:
R, Shapiro, M L, Jordan, V P, Scantlebury, C, Vivas, H A, Gritsch, L, Fox-Hawranko, H R, Doyle, L B, Johnson, R, Fenton, L, Painter, K, Keefer-Wolf, C, Redman, J, McCauley, J J, Fung, T R, Hakala, T E, Starzl, R L, Simmons
Publikováno v:
Clinical transplantation. 12(5)
The need to reduce the costs associated with the initial hospitalization for kidney transplantation has led to the development of outpatient facilities in which patients can be seen on a daily basis. The implementation of a kidney transplant intensiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::125dfe83809e1010e8fd5453095841c0
https://pubmed.ncbi.nlm.nih.gov/9787961
https://pubmed.ncbi.nlm.nih.gov/9787961
Autor:
R, Purighalla, R, Shapiro, M L, Jordan, V P, Scantlebury, H A, Gritsch, C, Vivas, P S, Randhawa
Publikováno v:
Clinical transplantation. 11(6)
There is a reciprocal relationship between post-transplant lymphoproliferative disorder (PTLD) and rejection: aggressive treatment of rejection can result in PTLD, while treatment of PTLD by reducing immunosuppression can result in recrudescence of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68c72da2548f7b3c2a7e24dad1390519
https://pubmed.ncbi.nlm.nih.gov/9408687
https://pubmed.ncbi.nlm.nih.gov/9408687
Autor:
M L, Jordan, R, Naraghi, R, Shapiro, D, Smith, C A, Vivas, V P, Scantlebury, H A, Gritsch, J, McCauley, P, Randhawa, A J, Demetris, J, McMichael, J J, Fung, T E, Starzl
Publikováno v:
Transplantation. 63(2)
Over the 5 year period from 7/14/1989 until 5/24/1994, we have attempted graft salvage with tacrolimus conversion in a total of 169 patients (median age 33 years, range 2-75 years) with ongoing rejection on baseline CsA immunosuppression after failur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a4beded0f014a543b7d593b6fc3c51a2
https://pubmed.ncbi.nlm.nih.gov/9020321
https://pubmed.ncbi.nlm.nih.gov/9020321
Autor:
R, Shapiro, V P, Scantlebury, M L, Jordan, C, Vivas, H A, Gritsch, D, Ellis, N, Gilboa, S, Lombardozzi-Lane, W, Irish, J J, Fung, T R, Hakala, R L, Simmons, T E, Starzl
Publikováno v:
Transplantation. 62(12)
Tacrolimus was used as the primary immunosuppressive agent in 69 pediatric renal transplantations between December 17, 1989, and June 30, 1995. Children undergoing concomitant or prior liver and/or intestinal transplantation were excluded from analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc5dd7ea8cb5643c09d905644edbab06
https://pubmed.ncbi.nlm.nih.gov/8990356
https://pubmed.ncbi.nlm.nih.gov/8990356
Autor:
V P, Scantlebury, R, Shapiro, J, McCauley, M, Jordan, C, Vivas, W, Irish, A, Tzakis, D, Ellis, N, Gilboa, T E, Starzl
Publikováno v:
Transplantation proceedings. 27(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2947b6d324be8766cb2ef2010c97d6c
https://pubmed.ncbi.nlm.nih.gov/7533436
https://pubmed.ncbi.nlm.nih.gov/7533436
Autor:
R, Shapiro, M, Jordan, V P, Scantlebury, C, Vivas, H A, Gritsch, A S, Rao, M, Trucco, A, Zeevi, A J, Demetris, P, Randhawa
Publikováno v:
Clinical transplants.
1. In an unselected adult renal transplant population, FK506 as the primary immunosuppressive agent yielded one- and 2-year actuarial patient survival rates of 95% and 93% and one- and 2-year actuarial graft survival rates of 89% and 83%, respectivel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb957da9bbf4af41ae71dca40d821cd5
https://pubmed.ncbi.nlm.nih.gov/7547544
https://pubmed.ncbi.nlm.nih.gov/7547544